|
July 30, 1997
Dear IC Questionnaire Participant:
I imagine that by now you might have forgotten all the work you did in filling out the CRC/ICIC
questionnaire that was sent to you last fall, but we (Dr. Fugazzotto and I) have not forgotten you.
Thanks to all your input (both positive and negative) we have come up with a definite indication that the
CRC monitoring program for pelvic symptoms/IC does work and works extremely well for many IC patients. It
has taken many months and hundreds of hours of work to compile this information but it is now completed.
Enclosed is a copy of the abstract and general conclusions reached by the compilation of all questionnaire
participants. I think you will find them to be most interesting to say the least As we had no funding source
for 17 months of work and effort to complete this questionnaire, I am sorry to say I canŐt send the complete
set of conclusions to you unless you would be willing to send $6.50 in order to receive such a copy. The
report itself is 11 pages long with four charts making a total of 15 pages.
If you do want the complete report, please send a check for $5.50 made payable to Kay H. Benton and I'll
get a copy out to you by return mail if at all possible. If any of you are further interested in receiving
the ICIC info listing (free) and info regarding the IC Supplement Program (first ever to be put together
specifically for IC patients), please also indicate that on the note you send with your request and
I'll be happy to send that to you also.
Dr. Fugazzotto and I hope most of you are continuing to do well with your IC and/or as many of you
indicated continue to enjoy a healed bladder and freedom from IC symptoms. We thank you again for
adding your pertinent information to this most valuable study determining the efficacy of the CRC
monitoring program for IC patients.
Sincerely,
Kay H. Benton, Director
Participants in the Cystitis Research Center Monitoring Program
Fugazzotto, Paul and Benton, Kay H. Rapid City, SD and Farmville, VA
As a former sufferer of Interstitial Cystitis and participant in the Cystitis Research Center (CRC)
Program under the monitoring of Dr. Paul Fugazzotto, I became interested in collecting all the information
I could find on IC: research publications, news reports, personal experiences, etc.
In the past 12 years I have accumulated hundreds of pieces of informational material which I began to put to
use to help other IC victims by establishing the IC Information Center in early 1995.
A study of these articles shows that none of them can claim a measure of success comparable to that of
the work of the CRC technology for diagnosis and monitoring of IC that I received. Since 1986, Dr.
Fugazzotto has tested more than 8800 urine specimens from chronic symptomatic women (mostly) for a
roster of over 1700 participants. With all this accumulation of data, I approached Dr. Fugazzotto
on the desirability of conducting a nationwide clinical survey of his CRC participants' histories
for a validated scientific approach to the identity of IC. He readily agreed but left the design
of the survey to my discretion and merely provided the listing of 1000 inactive patients names and
addresses to a mailing agency in Rapid City, SD whose computers randomly selected one of every five
names to receive the survey by bulk mail, The survey, mailed out in the fall of 1996, was
accompanied by an addressed envelope to be returned to me at the ICIC for analysis and tabulation.
The content of this survey consisted of 50 questions referring to pelvic disorders/IC experiences
contained in three parts: Part A: Prior to Participating in the CRC Monitoring Program (18 questions);
Part B: Participation in the CRC Monitoring Program (12 questions); and Part C: General Questions (20 questions).
While an actual count of diagnosed IC participants was not made, the surveys submitted indicated that nearly
all returns were made by IC patients having urine specimens yielding historically established Gram Positive
coccus pathogens.
Responses were tabulated and a basic summary of results was concluded. These conclusions are attached
to this abstract. Most importantly, in contrast to the nearly complete failure in the management of
these patients by standard testing and traditional antibiotic and/or invasive treatments prior to
their CRC participation, the CRC participants showed a success rate of 78% in that their pelvic disorders/IC
symptoms were LESS in ALL categories while under the CRC monitoring program. That success rate would appear
to have been even higher if various breaks in the participation chain had not occurred.
No funding by ICA or NIH
GENERAL CONCLUSIONS TO THE NATIONWIDE CLINICAL SURVEY OF RESPONSES BY A SAMPLE OF PARTICIPANTS IN
THE CYSTITIS RESEARCH MONITORING PROGRAM:
The survey results show the efficacy of Dr. Paul Fugazzotto's Cystitis Research Center monitoring
program of individuals with pelvic symptoms/IC. Sixty-eight percent (68%) of the respondents showed
symptom reduction taking the CRC suggested antibiotics within "DAYS" and/or "SIX MONTHS. If there
was a problem with the antibiotic being taken or the dosages taken 75% of those who made the suggested
changes found them to be helpful. It was learned from this survey that the average continuous time
using CRC suggested antibiotics was 16 months, not the years and years that many IC patients have
heard or felt would be necessary in order to rid their bodies of IC bacteria. It was also learned
that the average age of onset for pelvic symptom/IC was 36 1/2 years as opposed to the accepted
thinking that most IC patients are middle-aged and either peri-menopausal or menopausal.
Sixty percent (60%) of those who stayed with the CRC monitoring program now feel their bladders
are HEALED, have only slight symptoms needing occasional antibiotic usage or no longer feel they
need antibiotics at all.
Seventy-two percent (72%) ranked the CRC monitoring program "fair" to "excellent".
Seventy-eight percent (78%) felt their pelvic symptoms/IC were LESS in all categories while
under the CRC monitoring program.
Eighty-two percent (82%) said they would and have recommended the CRC monitoring program to others.
Sixty-nine percent (69%) reported they had complete remissions in their symptoms anywhere from
two weeks (1) to four or five years. When asked if they were currently symptom-free, forty-nine
percent (49%) said they were.
Also encouraging was the fact that eighty-two percent (82%) of the respondents had implemented
dietary controls and found them to be helpful. Interestingly, however, sixty-one percent (61%)
did NOT think they had food, drug, chemical sensitivities or other types of allergies that caused
them problems in their treatments. And an impressive eighty-seven percent 87% reported that they
do take vitamin/mineral supplements to help them improve their overall health.
|